日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Racial and Ethnic Survival Disparities Among Children With High-Risk Neuroblastoma: A Children's Oncology Group Report

儿童肿瘤协作组关于高危神经母细胞瘤患儿种族和民族生存差异的报告

Umaretiya, Puja J; Naranjo, Arlene; Zhang, Fan F; Park, Julie R; Weiss, Brian D; Granger, Meaghan; Desai, Ami V; Ozkaynak, M Fevzi; Yu, Alice L; Aziz-Bose, Rahela; Pruitt, Sandi L; DuBois, Steven G; Bagatell, Rochelle; Bona, Kira

Expression of neuroblastoma-related genes in bone marrow at end of high-risk neuroblastoma therapy

高危神经母细胞瘤治疗结束时骨髓中神经母细胞瘤相关基因的表达

Asgharzadeh, Shahab; Marachelian, Araz; Villablanca, Judith G; Liu, Wei Yao; Kennedy, Rebekah; Sposto, Richard; Naranjo, Arlene; Tenney, Sheena; Yu, Alice L; Ozkaynak, M Fevzi; Sondel, Paul M; Park, Julie R; Seeger, Robert C

Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032

ch14.18(Dinutuximab)+细胞因子免疫疗法治疗高危神经母细胞瘤患儿的III期研究的长期随访:COG研究ANBL0032

Yu, Alice L; Gilman, Andrew L; Ozkaynak, M Fevzi; Naranjo, Arlene; Diccianni, Mitchell B; Gan, Jacek; Hank, Jacquelyn A; Batova, Ayse; London, Wendy B; Tenney, Sheena C; Smith, Malcolm; Shulkin, Barry L; Parisi, Marguerite; Matthay, Katherine K; Cohn, Susan L; Maris, John M; Bagatell, Rochelle; Park, Julie R; Sondel, Paul M

Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

神经母细胞瘤患者的KIR和KIR配体基因型影响基于Dinutuximab的免疫疗法的临床疗效:来自儿童肿瘤协作组的报告

Erbe, Amy K; Wang, Wei; Carmichael, Lakeesha; Kim, KyungMann; Mendonça, Eneida A; Song, Yiqiang; Hess, Dustin; Reville, Patrick K; London, Wendy B; Naranjo, Arlene; Hank, Jacquelyn A; Diccianni, Mitchell B; Reisfeld, Ralph A; Gillies, Stephen D; Matthay, Katherine K; Cohn, Susan L; Hogarty, Michael D; Maris, John M; Park, Julie R; Ozkaynak, M Fevzi; Gilman, Andrew L; Yu, Alice L; Sondel, Paul M

A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931

一项针对接受骨髓清除治疗的高危神经母细胞瘤患者的嵌合抗体 14.18 联合 GM-CSF、IL-2 和异维A酸的综合安全性试验:儿童肿瘤协作组研究 ANBL0931

Ozkaynak, M Fevzi; Gilman, Andrew L; London, Wendy B; Naranjo, Arlene; Diccianni, Mitchell B; Tenney, Sheena C; Smith, Malcolm; Messer, Karen S; Seeger, Robert; Reynolds, C Patrick; Smith, L Mary; Shulkin, Barry L; Parisi, Marguerite; Maris, John M; Park, Julie R; Sondel, Paul M; Yu, Alice L

Study on relationships among deep vein thrombosis, homocysteine & related B group vitamins

深静脉血栓形成、同型半胱氨酸及相关B族维生素之间关系的研究

Ekim, Meral; Ekim, Hasan; Yilmaz, Yunus Keser; Kulah, Bahadir; Polat, M Fevzi; Gocmen, A Yesim

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma

抗GD2抗体联合GM-CSF、白细胞介素-2和异维A酸治疗神经母细胞瘤

Yu, Alice L; Gilman, Andrew L; Ozkaynak, M Fevzi; London, Wendy B; Kreissman, Susan G; Chen, Helen X; Smith, Malcolm; Anderson, Barry; Villablanca, Judith G; Matthay, Katherine K; Shimada, Hiro; Grupp, Stephan A; Seeger, Robert; Reynolds, C Patrick; Buxton, Allen; Reisfeld, Ralph A; Gillies, Steven D; Cohn, Susan L; Maris, John M; Sondel, Paul M

Phase I study of ch14.18 with granulocyte-macrophage colony-stimulating factor and interleukin-2 in children with neuroblastoma after autologous bone marrow transplantation or stem-cell rescue: a report from the Children's Oncology Group

儿童肿瘤协作组 (Children's Oncology Group) 的一项 I 期研究报告显示,在接受自体骨髓移植或干细胞移植的神经母细胞瘤患儿中,使用 ch14.18 联合粒细胞-巨噬细胞集落刺激因子和白细胞介素-2 进行治疗效果良好。

Gilman, Andrew L; Ozkaynak, M Fevzi; Matthay, Katherine K; Krailo, Mark; Yu, Alice L; Gan, Jacek; Sternberg, Adam; Hank, Jacquelyn A; Seeger, Robert; Reaman, Gregory H; Sondel, Paul M

Detection of central nervous system leukemia in children with acute lymphoblastic leukemia by real-time polymerase chain reaction

利用实时聚合酶链式反应检测儿童急性淋巴细胞白血病中的中枢神经系统白血病

Pine, Sharon R; Yin, Changhong; Matloub, Yousif H; Sabaawy, Hatem E; Sandoval, Claudio; Levendoglu-Tugal, Oya; Ozkaynak, M Fevzi; Jayabose, Somasundaram